COVID-19 and the pituitary

Background Despite COVID-19 being identified as severe respiratory viral infection, progressively many relevant endocrine manifestations have been reported greatly contributing to the severity of the clinical presentation. Systemic involvement in COVID-19 is due to the ubiquitous expression of angio...

Full description

Saved in:

Bibliographic Details
Published in:	Pituitary Vol. 24; no. 3; pp. 465 - 481
Main Authors:	Frara, Stefano, Allora, Agnese, Castellino, Laura, di Filippo, Luigi, Loli, Paola, Giustina, Andrea
Format:	Journal Article
Language:	English
Published:	New York Springer US 01.06.2021 Springer Nature B.V
Subjects:	ACE2 Adrenocorticotropic hormone Angiotensin Angiotensin-converting enzyme 2 Angiotensin-Converting Enzyme 2 - metabolism Animal models Animals Comorbidity Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - physiopathology COVID-19 - therapy COVID-19 - virology Cushing syndrome Cushing's disease Diabetes Diabetes mellitus Endocrinology Gene expression Host-Pathogen Interactions Human Physiology Humans Hypopituitarism Hypothalamus Medicine Medicine & Public Health Nervous system diseases Neurosurgery Pandemics Peptidyl-dipeptidase A Phenotypes Pituitary Pituitary Diseases - epidemiology Pituitary Diseases - physiopathology Pituitary Diseases - therapy Pituitary Diseases - virology Pituitary gland Pituitary Gland - metabolism Pituitary Gland - physiopathology Pituitary Gland - virology Prognosis Receptors, Virus - metabolism Risk Assessment Risk Factors SARS-CoV-2 - pathogenicity Severe acute respiratory syndrome coronavirus 2 Vaccination Vertebrae Virus Internalization Pituitary apoplexy COVID-19 Hyponatremia Hypopituitarism Acromegaly SIADH Cushing disease
ISSN:	1386-341X, 1573-7403, 1573-7403
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!